General Information

C3i Center Inc.

	Address	5151 Boulevard De L'assomption Montréal, H1T 4A9 Canada
	Address type	Registered Office Address
	Address province	Quebec

	Corporation ID	9591036
	Business number	787733690
	Status	Active
	ACT	Canada Not-for-profit Corporations Act
	Anniversary date	01/19/2016
	Last annual filing	2026
	Data verified	10/31/2026

Description

C3I Center Inc. is an active business which was registered under Canada Not-for-profit Corporations Act with a corporation number 9591036 (business no 787733690). The financial statement was conducted on 2019-10-16. The company is located in Montréal at 5151 Boulevard De L'assomption, H1T 4A9 in Quebec province.
Additional businesses in the proximity include: 3345831 Canada Inc., Pela Concept Inc., 4330552 Canada Inc., Gtic Conseil Inc., 8339368 Canada Inc..

Location: Statistics Canada, Open Database of Addresses (Open Government Licence – Canada).

Company names

Name	Effective date	Type	Current
Centre for Commercialization of Cancer immunotherapy (C3i)	01/19/2016	Corporate Name
Centre pour la commercialisation de l'immunothérapie du cancer (C3i)	01/19/2016	Corporate Name in the other official language (if applicable)
Centre C3i inc.	11/01/2026	Corporate Name in the other official language (if applicable)
C3i Center Inc.	11/01/2026	Corporate Name	true

Directors

William Brock
,

Louis Lacasse
,

Thomas Tradler
,

Chantale Lauzon
,

Sylvain Lemieux
,

Isabelle Riviere
,

Denis Claude Roy
,

Lambert Busque
,

Janet Dancey
,

Kathryn Hayashi
,

Tim Smith
,

Bernard Massie
,

Allen Eaves
,

last updated: 2026-10-30

Government Grants and Contributions

4 federal grants and contributions between 2021 and 2023 with a total value of $9,174,412.

Start date	Department and program	Value
11/06/2023	Canada Economic Development for Quebec Regions The Regional Economic Growth Through Innovation Program (REGI) (contribution) 600071327 Acquisition of equipment and professional fees: The project aims to increase the technology transfer capacity of an organization that supports companies specialized in cell therapy and cancer immunotherapy.	$3,000,000
11/06/2023	Canada Economic Development for Quebec Regions The Regional Economic Growth Through Innovation Program (REGI) (contribution) 600071327	$3,000,000
11/06/2023	Canada Economic Development for Quebec Regions The Regional Economic Growth Through Innovation Program (REGI) (contribution) 600071327 Equipment acquisition and professional fees: The project aims to increase the technology transfer capacity of an organization that supports companies specializing in cell therapy and cancer immunotherapy.	$2,500,000
04/01/2021	National Research Council Canada Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives (contribution) Infrastructure capacity modification to support cGMP-compliant manufacture of lentiviral vectors at CETC This Project aims at establishing a current Good Manufacturing Practices (cGMP)-compliant platform to manufacture clinical grade lentiviral vectors (including production, purification and quality control) at the Centre of Excellence for Cellular Therapy (CETC) of Hôpital Maisonneuve-Rosemont. It...	$674,412

Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.

Company activities

Date	Type	Section
10/16/2019	Financial Statement	0
09/13/2018	Financial Statement	0
05/24/2018	Financial Statement	0
08/29/2017	Amendment	51
01/19/2016	Incorporation